Loading
What changed between revision 1 and revision 2, compared over the article's markdown source with its frontmatter — so a change to status, evidence or reversibility shows up as the edit it is.
Older · revision 1
Import· initial corpus import, not an edit
Initial import of content/designer-babies.md — the filesystem corpus, unchanged. Not an edit.
11.5 kB
Revision 1
Revision 2
lines 7–13 → 7–136 unchanged lines not shown
categories: ["reproduction", "society"]categories: ["reproduction", "society"]tags: ["reproduction", "embryo selection", "germline", "bioethics", "genomics", "enhancement"]tags: ["reproduction", "embryo selection", "germline", "bioethics", "genomics", "enhancement"]summary: "A popular term for children whose traits are chosen before birth, covering a real but narrow practice of embryo selection and a largely hypothetical practice of embryo editing."summary: "A popular term for children whose traits are chosen before birth, covering a real but narrow practice of embryo selection and a largely hypothetical practice of embryo editing."updated: "2026-07-27"updated: "2026-10-29"issues: ["The claim about the size of achievable polygenic selection gains carries no source."]issues: ["The claim about the size of achievable polygenic selection gains carries no source."]------ lines 19–65 → 19–655 unchanged lines not shown
{ "label": "In circulation since", "value": "1990s" }, { "label": "In circulation since", "value": "1990s" }, { "label": "Realised form", "value": "Embryo selection", "link": "/wiki/embryo-selection" }, { "label": "Realised form", "value": "Embryo selection", "link": "/wiki/embryo-selection" }, { "label": "Hypothetical form", "value": "Heritable editing", "link": "/wiki/germline-editing" }, { "label": "Hypothetical form", "value": "Heritable editing", "link": "/wiki/germline-editing" }, { "label": "Known edited births", "value": "Three, 2018–2019", "link": "/wiki/he-jiankui-affair" }, { "label": "Known edited births", "value": "Three, 2018-2019", "link": "/wiki/he-jiankui-affair" }, { "label": "Main technical limit", "value": "Polygenicity" } { "label": "Main technical limit", "value": "Polygenicity" } ] ]}}`````` **Designer babies** is a popular term for children whose genetic characteristics have been deliberately chosen by their parents. It covers two very different things. One is [[embryo-selection]], which is routine in fertility clinics and can reliably deliver only a short list of outcomes. The other is heritable [[germline-editing]], which has been attempted once, illegally, and would face a different and harder set of technical obstacles. Most public argument treats the two as a single prospect, which is where the confusion begins.**Designer babies** is a popular term for children whose genetic characteristics have been deliberately chosen by their parents. It covers two very different things. One is [[embryo-selection]], which is routine in fertility clinics and can reliably deliver only a short list of outcomes. The other is heritable [[germline-editing]], which has been attempted once, illegally, and would face a different and harder set of technical obstacles. Most public argument treats the two as a single prospect, and much of the confusion around the term starts there. ## Origins of the term## Origins of the term The phrase is journalistic rather than technical, built on the same pattern as "designer drugs" and in wide circulation by the 1990s. It attached itself to a sequence of real clinical developments. In vitro fertilisation produced its first birth in 1978; preimplantation genetic diagnosis followed in 1990, when a British team biopsied embryos and selected female ones for couples at risk of X-linked disease.[^handyside1990] The film *Gattaca* fixed the popular image in 1997, some years before any of the genomic tools that would be needed to realise it existed.The phrase is journalistic, not technical. It follows the pattern of "designer drugs", was in wide circulation by the 1990s, and attached itself to a sequence of real clinical developments. In vitro fertilisation produced its first birth in 1978; preimplantation genetic diagnosis followed in 1990, when a British team biopsied embryos and selected female ones for couples at risk of X-linked disease.[^handyside1990] The film *Gattaca* fixed the popular image in 1997, some years before any of the genomic tools needed to realise it existed. A defining case arrived in 2000, when a couple used preimplantation diagnosis both to avoid Fanconi anaemia and to select an embryo whose tissue type matched their affected daughter's, so that cord blood from the resulting child could treat her.[^verlinsky2001] The "saviour sibling" framing dominated coverage for a decade and set the pattern for subsequent debate: a specific, medically motivated use, discussed as though it were the first step of a general capability.A defining case arrived in 2000, when a couple used preimplantation diagnosis both to avoid Fanconi anaemia and to select an embryo whose tissue type matched their affected daughter's, so that cord blood from the resulting child could treat her.[^verlinsky2001] The "saviour sibling" framing dominated coverage for a decade. It also set the pattern for later debate, in which a specific, medically motivated use was discussed as though it were the first step towards a general capability. ## What selection can actually deliver## What selection can actually deliver Selection is constrained by what the parents already carry. An IVF cycle produces a set of embryos that are recombinations of two existing genomes; no embryo can have an allele neither parent possesses. Within that set, selection is highly reliable for categorical outcomes determined by one locus or by chromosome count.Selection can only work with what the parents already carry. An IVF cycle produces a set of embryos that recombine two existing genomes, so no embryo can have an allele that neither parent possesses. Within that set, selection is highly reliable for categorical outcomes determined by one locus or by chromosome count. - **Single-gene disorders.** Where both parents carry a recessive allele, roughly a quarter of embryos are affected and can be identified with high accuracy. This is PGT-M, and it works.- **Single-gene disorders.** Where both parents carry a recessive allele, roughly a quarter of embryos are affected and can be identified with high accuracy. This is PGT-M, and it is reliable.- **Chromosomal aneuploidy.** PGT-A screens for the wrong number of chromosomes. Its value in improving live-birth rates remains debated, but the measurement itself is dependable.- **Chromosomal aneuploidy.** PGT-A screens for the wrong number of chromosomes. Its value in improving live-birth rates remains debated, but the measurement itself is dependable.- **Sex.** Sex is a categorical genetic fact, which is why it is the one non-medical trait selection delivers with near certainty, and why most jurisdictions that regulate embryo testing address it explicitly.- **Sex.** Sex is a categorical genetic fact. That makes it the one non-medical trait selection delivers with near certainty, and it is why most jurisdictions that regulate embryo testing address it explicitly.- **Tissue type.** HLA matching, as in the saviour-sibling case, is likewise a discrete genotype.- **Tissue type.** HLA matching, as in the saviour-sibling case, is likewise a discrete genotype. Everything else is probabilistic. [[polygenic-embryo-screening]] extends selection to traits shaped by thousands of variants, and the expected shift it can produce is a fraction of the variation within a single family. The constraint is not the accuracy of the laboratory work but the small genetic distance between siblings and the small number of embryos a cycle yields.Everything else is probabilistic. [[polygenic-embryo-screening]] extends selection to traits shaped by thousands of variants, and the expected shift it can produce is a fraction of the variation within a single family. The limit comes from the small genetic distance between siblings and the small number of embryos a cycle yields, and would remain even if the laboratory work were flawless. > [!key] The arithmetic that popular coverage skips> [!key] The arithmetic that popular coverage skips> A couple choosing among a handful of their own embryos is sampling from a narrow distribution. Even a perfect predictor of a trait could only pick the best of what those particular gametes happened to produce, which for most traits is a modest range.> A couple choosing among a handful of their own embryos is sampling from a narrow distribution. Even a perfect predictor of a trait could only pick the best of what those particular gametes happened to produce, which for most traits is a modest range. ## What editing would add, and what it would not## What editing would add, and what it would not Editing changes the constraint. [[crispr-cas9]] and its derivatives can in principle install an allele neither parent carries, which selection can never do. That matters in a small number of situations where selection genuinely fails: when one parent is homozygous for a dominant disease allele, when both are homozygous for a recessive one, or when a couple produces too few embryos for selection to have anything to work with. These cases are real but rare, and they are the strongest medical argument for heritable editing.Editing changes that constraint. [[crispr-cas9]] and its derivatives can in principle install an allele neither parent carries, which selection can never do. This matters in the few situations where selection genuinely fails: when one parent is homozygous for a dominant disease allele, when both are homozygous for a recessive one, or when a couple produces too few embryos for selection to have anything to work with. These cases are real but rare, and they are the strongest medical argument for heritable editing. For trait enhancement, editing runs into the same wall as selection, from a different direction. Traits such as height or cognitive test performance are influenced by thousands of variants, each shifting the outcome by a tiny amount, so a noticeable change means editing at a scale nobody has attempted in an embryo of any species. The number of changes required and the tolerance of a one-cell embryo for damage point in opposite directions. [[base-editing]] and [[prime-editing]], which rewrite a base without severing both strands of the helix, are the chemistries that would have to carry such an attempt; both were developed for single, well-characterised disease alleles rather than for thousands of small-effect ones. Nuclease editing at several sites at once carries a documented risk of the [[crispr-off-target-effects|large deletions and rearrangements]] that a biopsy of a few cells would not reliably detect.For trait enhancement, editing meets the same obstacle as selection from a different direction. Traits such as height or cognitive test performance are influenced by thousands of variants, each shifting the outcome by a tiny amount, so a noticeable change would require editing at a scale nobody has attempted in an embryo of any species. The more changes an edit requires, the more damage a one-cell embryo has to tolerate. [[base-editing]] and [[prime-editing]], which rewrite a base without severing both strands of the helix, are the chemistries any such attempt would have to use, and both were developed for single, well-characterised disease alleles rather than for thousands of small-effect ones. Nuclease editing at several sites at once carries a documented risk of the [[crispr-off-target-effects|large deletions and rearrangements]] that a biopsy of a few cells would not reliably detect. Embryos add a further problem. Editing a one-cell zygote often produces a mosaic, an individual whose cells do not all carry the intended change, and mosaicism cannot be reliably detected by biopsying a few trophectoderm cells. Research on non-viable and research-consented human embryos has reported edits at target loci, though the mechanism claimed in the most publicised case was disputed by other groups who argued that apparent correction reflected allele dropout rather than repair.[^ma2017] The [[he-jiankui-affair]] of 2018 illustrated the whole set of failures at once: the intended CCR5 deletion was not faithfully reproduced, at least one child was mosaic, and the medical rationale did not hold up.Embryos add a further problem. Editing a one-cell zygote often produces a mosaic, an individual whose cells do not all carry the intended change, and mosaicism cannot be reliably detected by biopsying a few trophectoderm cells. Research on non-viable and research-consented human embryos has reported edits at target loci, though the mechanism claimed in the most publicised case was disputed by other groups who argued that apparent correction reflected allele dropout rather than repair.[^ma2017] The [[he-jiankui-affair]] of 2018 showed the whole set of failures at once: the intended CCR5 deletion was not faithfully reproduced, at least one child was mosaic, and the medical rationale did not hold up. ## Polygenicity as the real constraint## Polygenicity as the real constraint The gap between the popular image and the genetics is almost entirely explained by polygenicity. Public discussion imagines a menu of traits with switches attached, because Mendelian disease provides the mental model and Mendelian disease is genuinely switch-like. Nearly everything people would want to choose is not.Polygenicity explains almost all of the gap between the popular image and the genetics. Public discussion imagines a menu of traits with switches attached, because Mendelian disease supplies the mental model and Mendelian disease really is switch-like. Nearly every trait people would want to choose is not. This is the central point of [[genetic-enhancement-of-intelligence]] and applies equally to athletic ability, temperament and appearance. The variants involved are numerous, individually negligible, context-dependent, and pleiotropic, meaning the same variant influences several traits at once. A technology that can flip one switch cleanly is not on a continuum with a technology that can retune ten thousand dials.This is the central point of [[genetic-enhancement-of-intelligence]], and it applies equally to athletic ability, temperament and appearance. The variants involved are numerous, individually negligible, context-dependent and pleiotropic, meaning the same variant influences several traits at once. Cleanly flipping one switch and retuning ten thousand dials are different problems, and the first is not an early stage of the second. > [!caution] What has actually been done> [!caution] What has actually been done> As of 2026 the only publicly documented births following deliberate genome editing remain the three children of the He Jiankui experiment. Everything else described as a designer baby has involved selecting among embryos, choosing a gamete donor, or, in the distinct case of [[mitochondrial-replacement-therapy]], substituting mitochondria rather than editing nuclear DNA.> As of 2026 the only publicly documented births following deliberate genome editing remain the three children of the He Jiankui experiment. Everything else described as a designer baby has involved selecting among embryos, choosing a gamete donor, or, in the distinct case of [[mitochondrial-replacement-therapy]], substituting mitochondria rather than editing nuclear DNA.lines 68–82 → 68–822 unchanged lines not shown
The ethical literature separates arguments that apply to selection from those that apply to editing. Selection debates centre on the expressivist objection developed within [[disability-rights-and-enhancement]], which holds that screening out a trait expresses a judgement about people who have it, and on [[procreative-beneficence]], Julian Savulescu's principle that parents have reason to choose the child expected to have the best life.[^savulescu2001] Editing debates add the questions of consent from a person who does not yet exist, of irreversibility across generations, and of the therapy-enhancement boundary examined in [[human-enhancement]].The ethical literature separates arguments that apply to selection from those that apply to editing. Selection debates centre on the expressivist objection developed within [[disability-rights-and-enhancement]], which holds that screening out a trait expresses a judgement about people who have it, and on [[procreative-beneficence]], Julian Savulescu's principle that parents have reason to choose the child expected to have the best life.[^savulescu2001] Editing debates add the questions of consent from a person who does not yet exist, of irreversibility across generations, and of the therapy-enhancement boundary examined in [[human-enhancement]]. Bioconservative critics, surveyed in [[bioconservatism]], argue that treating a child's characteristics as a parental design choice alters the relationship between generations regardless of whether the technique works. Distributional critics make a different argument, set out in [[access-and-inequality]]: a capability priced at the level of an IVF cycle plus genomic analysis is not evenly available, and one available only to the wealthy could compound advantage rather than health.Bioconservative critics, surveyed in [[bioconservatism]], argue that treating a child's characteristics as a parental design choice alters the relationship between generations regardless of whether the technique works. Distributional critics, whose case is set out in [[access-and-inequality]], argue something else. A capability priced at the level of an IVF cycle plus genomic analysis is not evenly available, and one available only to the wealthy could compound advantage rather than health. Law is fragmented. Heritable editing is prohibited outright in many countries and unfunded rather than banned in others; embryo testing is licensed condition-by-condition in some jurisdictions and unregulated in others. An international commission convened by national academies concluded that no clinical use of heritable editing should proceed until safety and efficacy could be established for a narrow set of indications, and that no country then had a pathway for authorising it.[^nasem2020] The details, and the weakness of enforcement, are covered in [[governance-of-genome-editing]].Law is fragmented. Heritable editing is prohibited outright in many countries and unfunded rather than banned in others. Embryo testing is licensed condition by condition in some jurisdictions and unregulated in others. An international commission convened by national academies concluded that no clinical use of heritable editing should proceed until safety and efficacy could be established for a narrow set of indications, and that no country then had a pathway for authorising it.[^nasem2020] The details, and the weakness of enforcement, are covered in [[governance-of-genome-editing]]. ## Outlook## Outlook Two technical developments would move the term closer to its popular meaning. [[in-vitro-gametogenesis]], if it works in humans, would turn selection from a choice among a handful of embryos into a choice among hundreds, which is the only route by which polygenic selection could produce changes large enough to notice. Reliable multiplex editing of embryos, with mosaicism solved, would remove the parental-genome constraint entirely.Two technical developments would move the term closer to its popular meaning. [[in-vitro-gametogenesis]], if it works in humans, would turn selection from a choice among a handful of embryos into a choice among hundreds, which is the only route by which polygenic selection could produce changes large enough to notice. Reliable multiplex editing of embryos, with the mosaicism problem solved, would remove the parental-genome constraint entirely. Neither is close, and the second may never be permitted. The open question is whether a capability that arrives gradually, one condition at a time and framed each time as disease prevention, ever confronts the public with the choice that "designer babies" names, or whether it simply passes without anyone having decided anything.Neither is close, and the second may never be permitted. The open question is whether a capability that arrives gradually, one condition at a time and framed each time as disease prevention, will ever confront the public with the choice that "designer babies" names, or whether it will arrive without anyone having decided anything. ## See also## See also removed, struck through added, underlinedLine numbers count the serialised markdown of each revision, frontmatter included.
81 lines are the same in both revisions, and 30 of them are not shown. Neither revision here is necessarily the current article — read Designer babies for the text this wiki stands behind today.